Browse our TRAF2 Proteins (TRAF2)

Human TNF Receptor-Associated Factor 2 (TRAF2) interaction partners

1. Depletion of TRAF2 inhibits gastric cancer cell growth, migration and invasion. The expression of TRAF2 is increased in gastric tumor tissue.

2. Results demonstrated that TRAF2 interacts physically with the N-terminal portion of FAK and colocalizes to cell membrane protrusions. This interaction was found to be critical for promoting resistance to cell anoikis. In breast cancer tissues, coamplification of TRAF2 and FAK was found to be predictive value for shorter survival, further supporting a potential role of TRAF2-FAK cooperative signaling in cancer progression.

3. Ubiquitin E3 ligase TRAF2 reduces BMAL1 protein level.BMAL1 interacts with the zinc finger domain in TRAF2.TRAF2 promotes BMAL1 ubiquitination and degradation.TRAF2 attenuates the BMAL1 transcriptional activity.

4. The authors found that tumor necrosis factor receptor-associated factor 2 (TRAF2), as well as TRAF1 and 3, directly binds to the active caspase-2 dimer.

5. The up-regulation of TRAF2 may play an important role in the inhibition of chondrocyte apoptosis of facet joint osteoarthritis (FJOA).

6. The TRAIP coiled-coil domain altered its stoichiometry between dimer and trimer in a concentration-dependent manner. Additionally, the TRAIP RING domain induced even higher-ordered assembly, which was necessary for interacting with the TRAF-N domain of TRAF2 but not TRAF1.

7. high levels of CASC9.5 expression promote the proliferation, metastasis and metabolism of lung adenocarcinoma cells and might serve as a prognostic indicator.

8. down-regulation of USP48 increases E-cadherin expression and epithelial barrier integrity through reducing TRAF2 stability

9. DR5-Cbl-b/c-Cbl-TRAF2 complex inhibited TRAIL-induced apoptosis by promoting TRAF2-mediated polyubiquitination of caspase-8 in gastric cancer cells.

10. CPNE1 overexpression can upregulate TRAF2 expression in prostate cancer DU-145 cells as determined by Western blotting and immunofluorescence assays.

11. TRAF2 functions as an important modulator in tumor metastasis and tumor microenvironment formation and is a novel independent prognostic factor of gastric cancer.

12. High expression of TRAF2 can predict poorer prognosis of GBM and was identified as an independent biomarker in GBM prognosis.

13. TRAF2 can influence in vitro growth of TRAIL-treated DU-145 cells at least partially via regulating SIRT1 expression.

14. Intestinal I/R induced the membrane translocation and phosphorylation of PKCzeta. Pretreatment with the PKCzeta activator phosphatidylcholine remarkably attenuated gut injury by suppressing apoptosis. H/R induced PKCzeta to combine with TRAF2, which was phosphorylated by PKCzeta at Ser(55), but not at Ser(11), under intestinal I/R or H/R conditions

15. In conclusion, for the first time, we report that TRADD, TRAF2, RIP1 and TAK1 play a role in the regulating TNF-alpha signalling in human myometrium. These findings are of significance given the central role of TNF-alpha in the processes of human labour and delivery.

16. Both S1P and caspase-8 are critical for TRAF2 stabilization, polyubiquitination, subsequent activation of JNK/AP1 signaling and MMP1 expression and final promotion of cell invasion.

17. Results showed that high expression of TRAF2 was significantly associated with tumor stage of prostate cancer.

18. The addition of nanomolar concentration of TRAF2 in GUVs also seems to exert a mechanical action.

19. TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling

20. destabilization of TRAF2 by miR-17 reduced the ability of TRAF2 to associate with cIAP2, resulting in the downregulation of TNF-alpha-induced NF-kappaBp65, c-Jun, and STAT3 nuclear translocation and the production of IL-6, IL-8, MMP-1, and MMP-13 in human rheumatoid arthritis synovial fibroblasts.

Mouse (Murine) TNF Receptor-Associated Factor 2 (TRAF2) interaction partners

1. Study findings demonstrate that RelB, involved in noncanonical NF-kappaB signaling, is upregulated by TRAF2 and is required for mediating the cytoprotective effects of TRAF2 overexpression in mouse model of myocardial infarction. Cytoprotective effects of TRAF2 are mediated by crosstalk between the canonical and noncanonical NF-kappaB signaling pathways, thereby revealing a complexity for NF-kappaB signaling in the heart.

2. The results demonstrate that gp130-associated TRAF2 and TRAF5 inhibit the interaction between two JAK proteins in the IL-6R complex that is essential for initiating the JAK-STAT signaling pathway.

3. TRAF2 is essential but TRAF3 is dispensable for T cell-dependent humoral immunity and CD40-induced class switch recombination

4. TRAF2 modulates the maximal Per1 mRNA level of the circadian clock.

5. Intestinal I/R induced the membrane translocation and phosphorylation of PKCzeta. Pretreatment with the PKCzeta activator phosphatidylcholine remarkably attenuated gut injury by suppressing apoptosis. H/R induced PKCzeta to combine with TRAF2, which was phosphorylated by PKCzeta at Ser(55), but not at Ser(11), under intestinal I/R or H/R conditions

6. work reveals that simulated microgravity promotes the apoptotic response through a combined modulation of the Uev1A/TICAM/TRAF/NF-kappaB-regulated apoptosis and the p53/PCNA- and ATM/ATR-Chk1/2-controlled DNA-damage response pathways.

7. Traf2 mediates the pro-survival pathway in the heart by suppressing necroptotic signaling.

8. Targeting TRAF2 may be useful as a therapeutic approach for immunosuppression-free islet allograft survival that avoids the thromboembolic complications associated with the use of anti-CD40L antibodies.

9. Celastrol promotes Nur77 migration from the nucleus to mitochondria, where it is ubiquitinated by TRAF2. Ubiquitinated Nur77 then interacts with p62/SQSTM1, leading to autophagy of dysfunctional mitochondria and alleviation of inflammation.

10. TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling

11. this study shows that TRAF2 and TRAF5 work as important regulators of the IL-6R signaling needed for Th17 development

12. Keratinocyte-specific deletion of Traf2, but not Sphk1 deficiency, disrupted TNF mediated NF-kappaB and MAP kinase signalling and caused epidermal hyperplasia and psoriatic skin inflammation.

13. TRAF2 functions as a key activator of MST1 in oxidative stress-induced intracellular signaling processes.

14. Proinflammatory TLR signalling is regulated by a TRAF2-dependent proteolysis mechanism in macrophages.

15. NFkappaB anti-apoptotic target genes TNF receptor-associated factor 1 (TRAF1), TNF receptor-associated factor 2 (TRAF2), cellular inhibitor of apoptosis (cIAP2), and Ferritin heavy chain (FTH1) were increased following Losartan treatment

16. These studies demonstrate a critical role for TRAF2 in the maintenance of peripheral CD8(+) CD44(hi) CD122(+) T-cell and NKT-cell homeostasis by modulating sensitivity to T-cell intrinsic growth factors such as IL-15.

17. HGK/MAP4K4 deficiency has a role in inducing TRAF2 stabilization and Th17 differentiation leading to insulin resistance

18. identifying the CYLD-TRAF2-p38MAPK pathway as a novel important regulator of HSC function restricting HSC cycling and promoting dormancy.

19. Data indicate that caspase-8 activity is lost upon deletion of c-FLIPL, and p43FLIP rescues caspase-8 activity through Raf1, TRAF2, and RIPK1 association, augmenting ERK and NF-kappaB pathways

20. IpaH0722 dampens the acute inflammatory response by preferentially inhibiting the PKC-mediated activation of NF-kappaB by ubiquitinating TRAF2, a molecule downstream of PKC, and by promoting its proteasome-dependent degradation.